Lyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel Disease
April 23 2018 - 3:18PM
Lyfebulb LLC and UnitedHealth Group (NYSE:UNH) invite patient
entrepreneurs to compete in “Empowering Patients: An Innovation
Challenge,” for the first-ever Lyfebulb and UnitedHealth Group
Innovation Award.
Established companies of all sizes founded by
patients, or people supporting patients who have inflammatory bowel
disease (IBD), and who have created a product or service to address
an issue encountered by IBD patients are invited to submit
applications between April 16 and May 31, 2018.
“Lyfebulb’s mission is to reduce the burden of
chronic disease,” said Dr. Karin Hehenberger, founder and CEO of
Lyfebulb. “We believe patient entrepreneurs have unique insights
into the needs of their communities and can create much-needed,
patient-driven solutions for problems they face. In addition to the
prize money, our events provide opportunities for exposure and
collaboration among these innovative entrepreneurs and the expert
jury.”
The 2018 Lyfebulb – UnitedHealth Group
Innovation Challenge will recognize the top patient entrepreneurs
developing innovative ideas for better management of Inflammatory
Bowel Disease (IBD) using healthcare information technology,
medical devices, consumer products or services. Patient
entrepreneurs are individuals with a chronic disease, or who have a
close relative or loved one with a chronic disease, and have
founded or lead a company bringing innovative solutions to the
market place. Companies based in the United States or Canada
(excluding Quebec) are eligible to apply through the Lyfebulb and
UnitedHealth Group Empowering Patients: An Innovation Challenge
website (www.lyfebulb.com/innovation-award/ibd), where more
information is available regarding eligibility and key
criteria.
After a thorough sourcing and screening process,
10 finalists will be selected by a joint steering committee
composed of Lyfebulb and UnitedHealth Group executives.
UnitedHealth Group will host the Empowering Patients event July
24-25, 2018, at its headquarters in Minnetonka, Minn. The finalists
will pitch their solutions to an esteemed panel of IBD experts from
the business, medical and patient communities. This jury will award
three prizes to the entrepreneurs with the most innovative and
impactful solutions: $25,000 to the winning entrepreneur, and
$15,000 and $10,000 to the second and third place finalists,
respectively.
“At UnitedHealth Group, we continually look for
new solutions that can improve the health and well-being for the
people we are privileged to serve, in this case for patients living
with chronic diseases, including IBD,” said Dr. Deneen Vojta,
UnitedHealth Group executive vice president, Research &
Development. “By leveraging patient-driven innovation, we can
accelerate getting the most relevant ideas, inspired by personal
experiences, into the marketplace.”
According to the Centers for Disease Control and
Prevention, up to 1.3 million people in the United States are
affected by IBD.
About LyfebulbLyfebulb is a
chronic disease focused, patient empowerment platform that connects
patients, industry (manufacturers and payers) and investors to
support user-driven innovation. Lyfebulb promotes a healthy,
take-charge lifestyle for those affected by chronic disease.
Grounded with its strong foundation in Diabetes, the company has
expanded disease states covered into Cancer and Inflammatory Bowel
Disease.
See www.lyfebulb.com, Facebook, Twitter, Instagram, Karin
Hehenberger LinkedIn, and Lyfebulb LinkedIn.
About UnitedHealth
GroupUnitedHealth Group (NYSE:UNH) is a diversified health
and well-being company dedicated to helping people live healthier
lives and helping make the health system work better for everyone.
UnitedHealth Group offers a broad spectrum of products and services
through two distinct platforms: UnitedHealthcare, which provides
health care coverage and benefits services; and Optum, which
provides information and technology-enabled health services. For
more information, visit UnitedHealth Group at
http://www.unitedhealthgroup.com/ or follow @UnitedHealthGrp on
Twitter.
Contact:
LyfebulbKarin Hehenberger, M.D., Ph.D.,
CEO917-575-0210; Karin@lyfebulb.com
UnitedHealth GroupTyler Mason424-333-6122,
tyler.mason@uhg.com
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Aug 2024 to Sep 2024
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Sep 2023 to Sep 2024